ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
Dow Jones
38,675.68
1.18%
Brent Oil
82.765
0.00%
Bitcoin
63,912.19
1.63%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. 60 Degrees Pharmaceuticals Inc (SXTP) Quote

60 Degrees Pharmaceuticals Inc

60 Degrees Pharmaceuticals Inc (SXTP)

NASDAQ
0.21
-0.022
(-9.48%)
Closed May 04 4:00PM
Delayed by 15 minutes
0.21
0.00
(0.00%)
After Hours: 5:33PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.21
Bid
0.2115
Ask
0.2304
Volume
204,071
0.2011 Day's Range 0.23
0.2011 52 Week Range 8.65
Market Cap
1.218M
Previous Close
0.232
Open
0.23
Last Trade
10
@
0.2115
Last Trade Time
Financial Volume
$ 43,524
VWAP
0.21328
Average Volume (3m)
214,060
Shares Outstanding
5,799,535
Dividend Yield
-
PE Ratio
-0.32
Earnings Per Share (EPS)
-0.65
Revenue
254k
Net Profit
-3.77M

About 60 Degrees Pharmaceuticals Inc

60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Its lead product, ARAKODA (tafenoquine), is an antimalar... 60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Its lead product, ARAKODA (tafenoquine), is an antimalarial indicated for the prophylaxis of malaria in patients aged 18 years and older. The Company's pipeline under development covers development programs for COVID-19, fungal, tick-borne, and other viral diseases; new products that contain the Arakoda regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. The ARAKODA regimen of tafenoquine is in Phase II study data in patients with mild-moderate COVID-19 disease. It is also planning a clinical study to assess the utility of ARAKODA as a treatment for human babesiosis. The Company is also developing Celgosivir for the treatment of COVID-19, respiratory syncytial virus (RSV), and dengue. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
60degreespharma.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
60 Degrees Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SXTP. The last closing price for 60 Degrees Pharmaceuticals was $0.23. Over the last year, 60 Degrees Pharmaceuticals shares have traded in a share price range of $ 0.2011 to $ 8.65.

60 Degrees Pharmaceuticals currently has 5,799,535 shares outstanding. The market capitalization of 60 Degrees Pharmaceuticals is $1.22 million. 60 Degrees Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.32.

SXTP Latest News

More News

60 Degrees Pharmaceuticals Receives FDA Comments on Tafenoquine-Babesiosis Clinical Trial Protocol; No Material Changes Required

Trial planning and execution to proceed as planned WASHINGTON, May 02, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company...

May 02 2024
GlobeNewswire Inc.

60 Degrees Pharmaceuticals to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis

Study to be conducted by North Carolina State University in 2024Standard of care fails in 20 percent of cases and drug resistance is a problemStandard of care is expensive WASHINGTON, April 03...

April 03 2024
GlobeNewswire Inc.

60 Degrees Pharmaceuticals Announces Communication from the FDA of Intention to Respond to Tafenoquine-Babesiosis Trial Protocol Submission in April, 2024

WASHINGTON, March 14, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc., (NASDAQ: SXTP, SXTPW) (“60 Degrees Pharmaceuticals” or the “Company”), a pharmaceutical company focused on...

March 14 2024
GlobeNewswire Inc.

Form 8-K - Current report

February 20 2024
Edgar (US Regulatory)

60 Degrees Pharmaceuticals to Sponsor Pre-Clinical Studies of Tafenoquine Use in Candida spp, Including Candida auris

Candida auris (C. auris) is a dangerous drug-resistant fungal pathogen emerging in U.S. hospitalsTafenoquine’s presumed mode of action against C. auris is differentiated from standard of care...

February 20 2024
GlobeNewswire Inc.

60 Degrees Pharmaceuticals Appoints Kristen Landon as Chief Commercial Officer

To lead U.S. commercial relaunch of ARAKODA® (tafenoquine) for malaria preventionWill support Company plan to expand clinical research strategy in tick-borne diseases beyond acute babesiosis...

February 08 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

February 02 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

February 02 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.032-13.22314049590.2420.2450.20113843450.23242549CS
4-0.07-250.280.30.20111626660.24186261CS
12-0.057-21.34831460670.2670.3570.20112140600.27202368CS
26-0.37-63.79310344830.581.530.20114777370.78703553CS
52-3.54-94.43.758.650.20115506482.13018606CS
156-3.54-94.43.758.650.20115506482.13018606CS
260-3.54-94.43.758.650.20115506482.13018606CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BENFBeneficient
$ 6.8001
(254.17%)
31.01M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M
SHOTWSafety Shot Inc
$ 0.45
(45.16%)
644
AIPArteris Inc
$ 8.185
(38.03%)
1.11M
RGFReal Good Food Company Inc
$ 0.85
(37.32%)
4.26M
MNDRMobile health Network Solutions
$ 3.33
(-84.91%)
18.76M
NUVOHoldco Nuvo Group DG Ltd
$ 2.00
(-57.54%)
1.04M
SPTSprout Social Inc
$ 28.82
(-40.15%)
13.47M
UNITUniti Group Inc
$ 4.441
(-26.35%)
21.07M
IPDNProfessional Diversity Network Inc
$ 1.29
(-24.12%)
662.59k
AAPLApple Inc
$ 183.38
(5.98%)
163.22M
SQQQProShares UltraPro Short QQQ
$ 11.08
(-5.94%)
154.59M
JAGXJaguar Health Inc
$ 0.3164
(7.91%)
142.47M
NKLANikola Corporation
$ 0.6526
(6.55%)
106.88M
SGBXSafe and Green Holdings Corporation
$ 5.49
(87.37%)
92.18M

SXTP Discussion

View Posts
PennyStockTrader2 PennyStockTrader2 5 days ago
Continued to buy as it has stairstepped down now at 25K shares. I definitely expect a nice run at one point and will take profits appropriately though I dont have a specific plan in place yet, I would look to start selling in the .40s, also dependent on what the news is.
👍️0
PennyStockTrader2 PennyStockTrader2 3 months ago
I'd like to wring the neck of management for what they did. Luckily I took some profits in the .80s, only to see it drop to .30 and below where I have picked up a little and would buy more at .29. At this price it should be safely priced. When it spikes back up I dont know.
👍️0
Awl416 Awl416 3 months ago
60 Degrees Pharmaceuticals Announces Pricing of $2.4 Million Public Offering
👍️0
PennyStockTrader2 PennyStockTrader2 3 months ago
Taken on new position in SXTP on this downdraft. This is more of a shorter term trade looking for it to go back over a buck, lets see.
👍️0
DERBYBLOOD DERBYBLOOD 4 months ago
WHO is the idiot trying to sell 78K shares @ $1.09 ALL AT ONCE ??? Break UP that sell order genius....Are you TRYING to create a wall / stop a run?
👍️0
TommyBoyTrader9460 TommyBoyTrader9460 4 months ago
$SXTP
https://x.com/hannahadad8890/status/1739964080163541132?s=61
👍️0
TheFinalCD TheFinalCD 4 months ago
https://finviz.com/quote.ashx?t=SXTP&p=d
https://dilutiontracker.com/app/search/SXTP
👍️0
TommyBoyTrader9460 TommyBoyTrader9460 4 months ago
Absolutely agree..
👍️0
81vette 81vette 4 months ago
Has a “thinking about buying” promoters dumping on all 3 right now,once they done,if they don’t destroy it and enough ppl see potential it might go up,has to have excellent financials and astronomical potential for continuation
👍️0
Awl416 Awl416 4 months ago
Wild
👍️0
Awl416 Awl416 4 months ago
Don’t mess with algo’s
👍️0
Awl416 Awl416 4 months ago
Half the float is traded and this about to go red

👍️0
TommyBoyTrader9460 TommyBoyTrader9460 4 months ago
$SXTP
https://x.com/hannahadad8890/status/1737839683814768844?s=61
👍️0
Awl416 Awl416 4 months ago
Algo’s once again ruining a ticker. The spread was as high as .12 yesterday

What a market
👍️0
Muhbruh Muhbruh 5 months ago
$SXTP 19.9% 13Ghttps://t.co/2TGdN884FX pic.twitter.com/5Lizh4wZKG— STOCKS Gambino (@StocksGambino) December 18, 2023
👍️0
Disquisition Disquisition 7 months ago
INSCRUTABLE DUMPING
👍️0
Disquisition Disquisition 8 months ago
INDESCRIBABLE DUMPING
👍️0
Awl416 Awl416 8 months ago
60 Degrees Pharmaceuticals Receives Additional U.S. Patent Covering Tafenoquine for Prevention of Plasmodium Falciparum Malaria
👍️0
hazarderk hazarderk 9 months ago
Not when they dilute unlimited
👍️0
Stockexpertpro Stockexpertpro 9 months ago
SXTP News Low Float Recent IPO no resistance above 2.50$
👍️0
AJ Freely AJ Freely 9 months ago
$SXTP - 👆Up 13.7% Pre-Market/ Current Price $2.43
Awarded Canadian Patent Covering Tafenoquine for Prevention of Malaria in Malaria-Naive Subjects
👍️0
Willy Willy 9 months ago
All your predictions are wrong on every board. No one believes anything you post.
👍️0
Pedro2004 Pedro2004 9 months ago
Wow. Down to $2.01 yesterday. -- We'll have to wait for the 10Q to see what type of scam they're pulling.
👍️0
Pedro2004 Pedro2004 9 months ago
I don't see that happening anytime in the near future.
👍️0
hondaboost hondaboost 9 months ago
SXTP, a garbage and scam, that's why everybody is shorting it. Dead Cat!
👍️0
saigai saigai 10 months ago
i think tomorrow will be a good day..only a darn fool would short it here. solid volume and base. i say it runs hard am pre ..we shall see
👍️0
Volcano Volcano 10 months ago
Patience always pay off
👍️0
Triple nickle Triple nickle 10 months ago
Here goes
👍️0
saigai saigai 10 months ago
maybe if folks dont scalp every 2 cent... thats what happens when the confidence in the game is not what it use to be
👍️0
Inve$tor77 Inve$tor77 10 months ago
$SXTP super low float post IPO. Could get interesting.
👍️0
Triple nickle Triple nickle 10 months ago
Bots got it
👍️0
AJ Freely AJ Freely 10 months ago
$SXTP -Up 40% Pre-Market/ Current Price $3.36
Offers a robust range of capital markets and investment banking services to the healthcare community.
IPO on July 12 (Wed)
Super Low Float-near 2 million
👍️0
Harbor6460 Harbor6460 10 months ago
Guess not. 1.00
👍️0
stock1ace1 stock1ace1 10 months ago
A little off there ?
👍️0
Volcano Volcano 10 months ago
Huge short squeeze coming
👍️0
Volcano Volcano 10 months ago
Big bounce over $5.39 today
Buy all you can
👍️0
Pedro2004 Pedro2004 10 months ago
I know there was a lot of shorting on this company yesterday. But the short sellers don't attack a company like this...unless they know the Insiders are dumping their shares.
👍️0
tedgoeseast tedgoeseast 10 months ago
They have hardly no revenue or profits if you read the financial information,I couldnt believe peeps where buying this like hotcakes yesterday and if they didn't get out they are now all selling for a big loss
👍️0
Pedro2004 Pedro2004 10 months ago
Looking more and more like a scam company. Premarket is at $3.90
👍️0
Volcano Volcano 10 months ago
https://60degreespharma.com/
👍️0
Volcano Volcano 10 months ago
This new IPO company has many news to release now
I see $20 coming faster with just 5 mil OS
👍️0
Volcano Volcano 10 months ago
They have FDA approved malaria prevention drug associated with Bill gate foundation
That is huge indeed
👍️0
Volcano Volcano 10 months ago
Looks very interesting IPO play
👍️0
tedgoeseast tedgoeseast 10 months ago
Did you hold sxtp today or take a excellent profit at open at 8.65
👍️0
Triple nickle Triple nickle 10 months ago
Break 7.50 then on to 9.00
👍️0
Triple nickle Triple nickle 10 months ago
There she goes ……again
👍️0
Invest-in-America Invest-in-America 10 months ago
SXTP: Now at THIRD place from the TOP on Fidelity's "MARKET MOVERS" list --- one of the most IMPORTANT daily stock lists on the Planet.

👍️0
Triple nickle Triple nickle 10 months ago
Back to 7.25
👍️0
Invest-in-America Invest-in-America 10 months ago
SXTP: Pursuant to a Direct Order from iHub's Invest-In-America, the SXTP stock may now commence FIRING!!!!

👍️0
Triple nickle Triple nickle 10 months ago
Engine failure
👍️0

Your Recent History

NASDAQ
SXTP
60 Degrees Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved